Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Isaković J et al. | 2024 | intact cell/cell culture, neural stem cells derived from B6 albino mouse embryos | magnetic field, 50/60 Hz, signals/pulses | - |
| Wang Z et al. | 2024 | intact cell/cell culture, RSC96 cells, animal, rat/Sprague Dawley | 50/60 Hz, magnetic field, signals/pulses, also other exposures without EMF, co-exposure | - |
| Bajtoš M et al. | 2024 | intact cell/cell culture, HT-1080 (fibrosarcoma cells) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
| Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
| Rahimi S et al. | 2023 | intact cell/cell culture, dental pulp multipotent stromal stem cells | magnetic field, signals/pulses, 50/60 Hz | - |
| Shoorche AB et al. | 2023 | intact cell/cell culture, MG-63 cells (human osteosarcoma cell line) | magnetic field, low frequency, 50/60 Hz, signals/pulses | - |
| Anaya M et al. | 2023 | bacterium, <i>Candida guilliermondii</i> | magnetic field, 50/60 Hz, low frequency | - |
| Moya-Gómez A et al. | 2023 | intact cell/cell culture, BV2 cells (immortalized murine microglial cell line), SHSY5Y cells, (immortalized human neuroblastoma cell line), primary mouse microglia and neurons, animal, mongolian gerbils <i>(Meriones unguiculatus)</i> (stroke model) | 50/60 Hz, magnetic field | - |
| Vives L et al. | 2023 | intact cell/cell culture, human dermal fibroblasts | magnetic field, signals/pulses, 50/60 Hz, low frequency | - |
| Tekam CKS et al. | 2023 | intact cell/cell culture, C6 glial cells, animal, rat/Wistar | 50/60 Hz, magnetic field, signals/pulses | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
